Quality control and immunological activity of lentinan samples produced in China

Ying Wang,Hongyu Jin,Jiandong Yu,Changhai Qu,Qi Wang,Shuang Yang,Shuangcheng Ma,Jian Ni
DOI: https://doi.org/10.1016/j.ijbiomac.2020.05.050
IF: 8.2
2020-09-01
International Journal of Biological Macromolecules
Abstract:<p>Lentinan is widely used as a therapeutic agent for treatment of malignant tumors in clinical practice. The chemical structure of lentinan is highly associated with its biological activity. In this study, the correlation between the structure of lentinan and its immune activity was investigated to assess the function of key parameters that can influence quality control of lentinan. The results showed that the batch-to-batch consistency of two lentinan samples was satisfactory, indicating the stability of production process of lentinan. However, although the chemical composition and triple-helical conformation (THC) of the tested samples were relatively similar, their <em>M</em>w, polydispersity index (PDI), and <em>R</em>g<sub>z</sub> remarkably varied due to different production processes. <em>In vitro</em> immunomodulatory assay reflects that lentinan could stimulate the macrophages phagocytic capacity. Meanwhile, lentinan samples could improve the spleen and thymus indices, promote the proliferation of lymphocytes and adjust for the percentages of CD4+ and CD8+ T cells <em>in vivo</em>. Furthermore, the immunomodulatory effect of lentinan sample B (<em>M</em>w: 650,700 g/mol) was superior than that of the sample A (<em>M</em>w: 4,818,700 g/mol). It was noted that the <em>M</em>w should be detected as a necessary index for quality control of lentinan to ensure stability and effectiveness of the production process.</p>
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?